Omeros | OMER - Pre Tax Profit


Omeros reported $-65.12M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
Adma Biologics USD 57.13M 4.47M Mar/2026
Alnylam Pharmaceuticals USD 177.81M 43.85M Jun/2026
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Cytokinetics USD -206.03M 23M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Insmed USD -11.37M 150.72M Jun/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
MacroGenics USD -36.77M 21.84M Mar/2026
Omeros USD -65.12M 21.27M Jun/2024
Pacira USD 5M 4.43M Mar/2026
Pfizer USD -653M 5.84B Jun/2026
Rockwell Medical USD 343K 2.07M Jun/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sarepta Therapeutics USD -1.75M 344.92M Jun/2026
United Therapeutics USD 372.7M 54.4M Jun/2026
Vertex Pharmaceuticals USD 1.39B 138.9M Jun/2026